This page is solely managed by the hospital for all communications.
Dr. Piya Raani
Malignant lymphoma · Leukemia
Free Call - Call hospitals worldwide for free using the internet
Rabin Medical Center
Jerusalem District, Israel
39 Ze'ev Jabotinsky Street Jerusalem Jerusalem District Israel
Professor Piya Raani is the head of the day-stationary department of the Davidov Oncology Center of the Rabin Rabin Medical Center. Stationary departments in oncology centers are the inpatient units, where patients receive medical care and treatment while admitted to the hospital. These departments are staffed with highly trained medical professionals, including oncologists, nurses, and support staff who specialize in the treatment of cancer. Professor Piya Raani, who received a specialty at the Faculty of Medicine at the Hebrew University (Jerusalem, Israel), underwent an internship in the treatment of chronic myeloid leukemia at Hammersmith Hospital (London, UK). Professor Piya Raani holds the title of Professor at Tel Aviv University (Tel Aviv, Israel). The main areas of Professor Piya Raani's professional activity and scientific research include the treatment of diseases such as leukemia, chronic myeloid leukemia, tific research include the treatment of diseases such as leukemia, chronic myeloid leukemia, lymphoma, and lymphogranulomatosis. Professor Piya Raani is an expert in the fields of hematology and oncohematology. Oncohematology, also known as hematology-oncology or hemato-oncology, is a medical specialty that focuses on the diagnosis, treatment, and management of blood disorders and cancers of the blood and bone marrow. This specialty is concerned with the study of blood cells, their production and function, and the diseases that can affect them. Oncohematology is a sub-specialty of both oncology (cancer medicine) and hematology (blood medicine), and practitioners in this field are trained to manage a wide range of blood cancers and blood disorders, including leukemia, lymphoma, myeloma, anemia, bleeding disorders, and clotting disorders.